3,3'-Diindolylmethane
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3,3'-Diindolylmethane, covering 2016-02-01 to 2016-02-01. Get the full timeline:
Most recent: Clinical Trial Update: 3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus [Phase 1]